Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Working Capital Changes (2019 - 2025)

Bioadaptives' Other Working Capital Changes history spans 6 years, with the latest figure at -$100000.0 for Q2 2025.

  • For Q2 2025, Other Working Capital Changes changed N/A year-over-year to -$100000.0; the TTM value through Sep 2025 reached -$100000.0, changed N/A, while the annual FY2023 figure was $10000.0, 1100.0% up from the prior year.
  • Other Working Capital Changes for Q2 2025 was -$100000.0 at Bioadaptives, down from -$10000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $10000.0 in Q4 2023 and bottomed at -$100000.0 in Q2 2025.
  • The 5-year median for Other Working Capital Changes is -$1000.0 (2021), against an average of -$11111.1.
  • The largest annual shift saw Other Working Capital Changes plummeted 200.0% in 2022 before it soared 600.0% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $2000.0 in 2021, then tumbled by 200.0% to -$2000.0 in 2022, then skyrocketed by 600.0% to $10000.0 in 2023, then tumbled by 200.0% to -$10000.0 in 2024, then tumbled by 900.0% to -$100000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other Working Capital Changes are -$100000.0 (Q2 2025), -$10000.0 (Q1 2024), and $10000.0 (Q4 2023).